Vés al contingut

Catàleg de models animals del Vall d'Hebron Barcelona Hospital Campus

Utilitza el cercador per trobar els models que necessites per a la teva investigació.

Reference Name Animal specie Strain Thematic area Specific pathology Description
AT018 EAE - Experimental Autoimmune Encephalomyelitis - Relapsing-remitting model Mice (Mus musculus) SJL/J Neuroimmunology Multiple Sclerosis
EAE model presents both clinical and histopathological characteristics that are very similar to those of the human disease and it is widely used for drug screening or therapeutic approaches. SJL/J strain immunized with proteolipidic protein peptide 139-151 (PLP139-151) develops a relapsing-remitting clinical course.
AT017 EAE - Experimental Autoimmune Encephalomyelitis - Chronic progressive model Mice (Mus musculus) NOD Neuroimmunology Multiple Sclerosis
EAE model presents both clinical and histopathological characteristics that are very similar to those of the human disease and it is widely used for drug screening or therapeutic approaches. NOD strain immunized with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG 35-55) develops a chronic progressive clinical course.
AT016 EAE - Experimental Autoimmune Encephalomyelitis - Chronic model Mice (Mus musculus) C57BL/6J Neuroimmunology Multiple Sclerosis
EAE model presents both clinical and histopathological characteristics that are very similar to those of the human disease and it is widely used for drug screening or therapeutic approaches. C57BL6/J strain immunized with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG 35-55) develops a chronic clinical course.
AT015 Dry macular degeneration murine model Mice (Mus musculus) DKO rd8 (Ccl2-/-/Cx3cr1-/-/Crb1rd8/rd8) Diseases of the sense organs (skin, eyes and ears) Age-related macular degeneration
The DKO rd8 is obtained by crossing the C57BL/6NJ strain (homozygous for the Crb1rd8 mutation, the B6.129S4-*Ccl2tm1Rol*/J strain (homozygous for the Ccl2tm1Rol (Ccl2-/-) mutation), and the B6. 129P-*Cx3cr1tm1Litt*/J strain (homozygous for the Cx3cr1tm1Litt (Cx3cr1-/-) mutation). Availability: Cryopreserved
AT131 Drug-induced pathological Cardiac Remodelling mouse model Mice (Mus musculus) C57BL/6J Cardiovascular diseases Heart failure
Model generated by Implantation of subcutaneous angiotensin II release pump
AT130 Drug-induced pathological Cardiac Remodelling mouse model Mice (Mus musculus) C57BL/6J Cardiovascular diseases Heart failure
Model generated by Implantation of subcutaneous isoproterenol release pump
AT014 DIO (diet-induced obesity) Mice (Mus musculus) C567BL/6 Endocrinology Disorders of body’s energy balance; Obesity; Type 2 diabetes
This model exhibits servere obesity and altered glucose homeostasis (glucose intolerance and insulin resistance) after being fed with a high fat diet (45% Kcal from fat) or very high fat diet (60 % kcal from fat).
AT013 Diabetic rats by injection with streptozotocin (STZ) Rat (Rattus norvegicus) Long-Evans
Sprague-Dawley
Type 2 Diabetes; Type 1 Diabetes Diabetic Macular Edema
The low-dose streptozotocin model has been widely used for years in numerous publications with excellent results. The main advantage of drug delivery-based models is that the degree of β-cell disruption can be regulated according to the dose of toxin administered. This diabetic rat constitutes a good model because it generates vascular dysfunction and retinal neurodegeneration similar to human pathogenesis and allows obtaining sufficient amounts of retinal RNA or protein for experimental procedures. 1 dose of 65 mg/kg of STZ solution intraperitoneally. A week after stabilization, weight and blood glucose are measured. If the injected rats have a blood glucose level of > 250 mg/dl, they are considered diabetic.
AT012 Dexamethasone-induced Glaucoma Mice (Mus musculus) C57BL/6 Diseases of the sense organs (skin, eyes and ears) Glaucoma
Dexamethasone induces intraocular hypertension and a degeneration of the optic nerve
AT129 Cyclosporine (CsA)-induced Renal Toxicity model Mice (Mus musculus) C57BL/6 Nephrology Renal toxicity
Model generated by intramuscular injection of cyclosporine (CsA)

Sol·licitud de models animals

Aquest catàleg s'actualitza anualment. Per informació addicional i/o sol·licitar models animals, pots posar-te en contacte amb nosaltres a catalogo.animales@vhir.org.

També podeu cercar models animals a la Plataforma ISCIII de Biomodels i Biobancs.